Status:
UNKNOWN
Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia
Lead Sponsor:
National Research Center for Hematology, Russia
Conditions:
Septic Shock
Nonchemotherapy Drug-induced Neutropenia
Eligibility:
All Genders
17-75 years
Phase:
PHASE1
PHASE2
Brief Summary
Septic shock remains a significant clinical problem associated with high rates of mortality among neutropenic patient despite antimicrobial therapy and supportive care. Recently, mesenchymal stromal c...
Detailed Description
All activities related to this human subjects research have been guided by ethical principles and have been reviewed and approved Federalwide Assurance National Ctr for Hematology, FWA00006482. The go...
Eligibility Criteria
Inclusion
- septic shock
- ≤10 hs after onset of septic shock severe neutropenia(≤ 1 10\^9/l) Patients ≥17 years Signed Informed Consent to treatment
Exclusion
- oncohematological patients with resistance to chemotherapy Unsigned Informed Consent to treatment Age \>75 years; Pregnancy
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01849237
Start Date
December 1 2012
End Date
May 1 2015
Last Update
May 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Research Center for Hematology
Moscow, Russia, 125167